Cannabis use during pregnancy and postpartum

Can Fam Physician. 2020 Feb;66(2):98-103.

Abstract

Objective: To help obstetric care providers, including family physicians, nurse practitioners, midwives, and obstetricians, educate patients on the risks of cannabis use in pregnancy and postpartum and its relationship to nausea and vomiting in pregnancy.

Sources of information: The Ovid MEDLINE database was searched using the MeSH terms pregnancy, cannabis, lactation, and cannabinoid hyperemesis in various combinations. The relevant articles were reviewed and further sources were found within the references of these articles.

Main message: In utero exposure to cannabis has been associated with long-term neurodevelopmental outcomes that persist into young adulthood. Cannabis should not be used to treat nausea and vomiting in pregnancy and its chronic use might lead to the development of cannabinoid hyperemesis syndrome.

Conclusion: There is no known safe level of cannabis use during pregnancy or lactation. Pregnant women should be counseled regarding the risks of in utero exposure and encouraged to abstain from use in pregnancy and while breastfeeding.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Cannabis / adverse effects*
  • Child
  • Child, Preschool
  • Dronabinol / pharmacology
  • Female
  • Humans
  • Hyperemesis Gravidarum / chemically induced
  • Infant
  • Infant, Newborn
  • Marijuana Use / adverse effects*
  • Neurodevelopmental Disorders / chemically induced
  • Postpartum Period
  • Pregnancy
  • Prenatal Exposure Delayed Effects / etiology*
  • Substance-Related Disorders / complications
  • Young Adult

Substances

  • Dronabinol